Results 51 to 60 of about 1,148 (137)

Medicine quality assessment in Nepal using semi randomised sampling and evaluation of a small scale dissolution test and portable Raman spectrometers

open access: yesScientific Reports
Substandard and falsified medicines threaten global health and require reliable data and screening technologies to combat their spread. This study examined the quality of 241 samples containing azithromycin, cefixime, esomeprazole and losartan collected ...
Robin Schreiber   +6 more
doaj   +1 more source

Igniting the spark in six countries to transform the trajectory of postpartum hemorrhage across the globe: An overview of the AMPLI‐PPHI project

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue S2, Page S9-S16, June 2026.
Abstract Postpartum hemorrhage (PPH) remains the leading cause of maternal mortality worldwide, disproportionately affecting women in low‐ and middle‐income countries. Despite updated WHO recommendations and the availability of newer technologies—including heat‐stable carbetocin, tranexamic acid as part of a clinical care bundle, misoprostol, and ...
Elaine Roman
wiley   +1 more source

Moving beyond a legacy paradigm: A vision for equitable access to quality medicines in Africa

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue S2, Page S44-S50, June 2026.
Abstract Ensuring the availability of quality medicines is fundamental to achieving health outcomes and safeguarding public health. However, in many low‐ and middle‐income countries, especially across Africa, the current quality assurance paradigm—largely driven by historical donor preferences for WHO prequalification and stringent regulatory authority
Naoko Doi   +9 more
wiley   +1 more source

Advancing Pharmacometrics in Africa: Insights and Perspectives From the 2025 Pharmacometrics Africa Conference

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1216-1222, May 2026.
Pharmacometrics (PMX) in Africa has transitioned from foundational capacity‐building to job creation, scientific leadership, regulatory influence, and health innovation. To accelerate this progress, the 2025 Pharmacometrics Africa Conference (PMXAC‐2025) convened key stakeholders to consolidate the continental PMX community, review progress in local ...
Babatunde Ayodeji Adeagbo   +12 more
wiley   +1 more source

A comprehensive analysis of selected medicines collected from private drug outlets of Dhaka city, Bangladesh in a simple random survey

open access: yesScientific Reports, 2022
Comprehensive data are needed to prevent substandard and falsified (SF) medicines as they pose a major risk to human health. To assess the quality of selected medicines, samples were collected from random private drug outlets of Dhaka North and South ...
Mohammad Sofiqur Rahman   +9 more
doaj   +1 more source

Fighting trafficking of falsified and substandard medicinal products in Russia

open access: yesInternational Journal of Risk & Safety in Medicine, 2015
BACKGROUND: The trafficking of falsified and substandard medicinal products is a global socio-economic problem, which poses a serious threat to economy and health of populations of most countries, including the Russian Federation. OBJECTIVE: To identify the main achievements and challenges in the fight against trafficking of falsified and substandard ...
openaire   +3 more sources

The Public Health Burden of Antimicrobial Resistance in Yemen: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aim Antimicrobial resistance is a global health crisis, with its impact magnified in conflict settings like Yemen, where a decimated health system and humanitarian emergency create ideal conditions for the proliferation of resistant pathogens.
Gamal Esam Ahmed Alsakkaf
wiley   +1 more source

The economic impact of substandard and falsified antimalarial medications in Nigeria.

open access: yesPLoS ONE, 2019
IntroductionSubstandard and falsified medications pose significant risks to global health. Nearly one in five antimalarials circulating in low- and middle-income countries are substandard or falsified.
Sarah M Beargie   +5 more
doaj   +1 more source

A randomised survey of the quality of antibiotics and other essential medicines in Indonesia, with volume-adjusted estimates of the prevalence of substandard medicines.

open access: yesPLOS Global Public Health
The World Health Organization warns that substandard and falsified medicines threaten public health in low- and middle-income countries. However, medicine quality surveys are often small and unrepresentative of the market, and the true scale of the ...
Elizabeth Pisani   +6 more
doaj   +1 more source

Quality Infrastructure for Resilient Pharmaceutical Manufacturing in Ethiopia: A Comparative Archival Review

open access: yesJournal of Critical Infrastructure Policy, Volume 7, Issue 1, Spring/Summer 2026.
ABSTRACT The National Quality Infrastructure (NQI) in a given country provides the essential framework for quality assurance integrating standardization, metrology, accreditation, and conformity assessment to create the technical backbone for industry and trade. Hence, building a resilient NQI is fundamental to securing medicine quality, enabling local
Addisu Afrassa Tegegne   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy